期刊文献+

PAI-1抗原及其启动子-675位点4G/5G基因多态性与冠心病的相关性研究 被引量:5

下载PDF
导出
摘要 目的探讨纤溶酶原激活物抑制物1(PAI-1)抗原多态性与冠心病(CHD)的相关性。方法采用PCR技术检测178例健康人(对照组)和293例CHD患者的(CHD组PAI-1基因多态性,用ELISA法测定其PAI-1抗原水平。结果CHD组-675位点与对照组三种基因型分布无统计学差异;与对照组比较,CHD组PAI-1抗原升高,以4G/4G基因型的PAI-1抗原最高,且与4G/5G、5G/5G基因型比较有统计学差异(P均<0.01),而对照组三基因型比较无统计学差异。结论PAI-1基因多态性与河南汉族人群CHD无明显相关性;PAI-1抗原水平与4G/4G基因型有相关性,是CHD发生原因之一。
出处 《山东医药》 CAS 北大核心 2009年第5期61-63,共3页 Shandong Medical Journal
  • 相关文献

参考文献6

  • 1Mansfield MW, Stiekland M, Grant PJ. Environmental and genetic factors in ralationto elevated circulating levelsof plasminogena ctivitorI nhibitor-I in caucasian patients with non-insulin-dependent diabetes mellitus[J]. Thrombosisa Ndh Aemostasis, 1995,74(3) :842-847.
  • 2Wiman B. Plasminogen Activtor Inhibitor 1 (PAl-1) in plasma: its role in thrombotic diseases [ J ]. Thrombosis and Haemostasis, 1995,74( 1 ) :71-76.
  • 3Ossei-Gerning N, Wilson LJ, Grant PJ, et al. Fibrinolysis in jeers with coronary artery diseasein coagulationand[ J ]. Thromb Haemost, 1998,79:736-740.
  • 4Kain K, Asian CAJ, Carter AM, et al. Decreased fibrinolytic poten-tial inbsouth women with ischaemic cerebrovascular disease [ J ]. British Journal of Haematology, 2001,114 : 155-161.
  • 5Ridker PM, Hennekens CH, Lindpaintner K, et al. Arterial and venous thrombosis is not associated with the 4G/SG polymorphism in the promotor of the plasminogen activator inhibitor gene in a large cohort of US men[J]. Circulation, 1997,95(6) :59-62.
  • 6Ye S, Green FR, Scarabin PY, et al. The 4G/SG genetic polymorphism in the promotor of the Plasminogen Activator Inhibitor I( PAI- l ) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infaction in the ECTIM study [ J ]. Thrombosis and Haemestasis, 1995,74( 3 ) :837-841.

同被引文献53

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部